On 11 July 2018, Knowledge Ecology International delivered the following statement on patents and health at the 28th session of WIPO’s Standing Committee on the Law of Patents (SCP). Statement of Knowledge Ecology International Agenda item 7 – Patents and… Continue Reading
On Monday, 9 July 2018, Knowledge Ecology International (KEI) made the following statement on exceptions and limitations to patent rights. KEI made the following proposal: In terms of future work on this item on exceptions and limitations to patent rights,… Continue Reading
In May 2017, the 70th World Health Assembly passed a cancer resolution (WHA70.12, Cancer prevention and control in the context of an integrated approach). At the time KEI provided the following commentary on the cancer resolution: On Tuesday, May 30,… Continue Reading
On June 28, 2018, the U.S. Senate provided the necessary advice and consent for ratification of the WIPO Marrakesh Treaty to Facilitate Access to Published Works for Persons Who Are Blind, Visually Impaired or Otherwise Print Disabled. At present, 39… Continue Reading
*(The author thanks Vitor Ido for his extensive notes of the 1st round of informal consultations held on 20 June 2018). On Thursday, 28 June 2018, the delegations of Brazil, Colombia, Mozambique, Portugal, and Thailand submitted a draft resolution on… Continue Reading
In June 2018, the European Union (EU) delivered the following statement on Intellectual Property and the Public Interest at the WTO TRIPS Council. The EU voiced a specific concern over a reference in the WTO submission by China and South… Continue Reading
As reported by Knowledge Ecology International (KEI) in May 2018, “[o]n 25 May 2018, the World Trade Organization (WTO) published a joint submission (IP/C/W/643) by China and South Africa to the TRIPS Council on Promoting Public Health Through Competition Law… Continue Reading
(Update: The NIH provided a response to our comments on July 16, 2018) Below are comments sent by KEI, UACT and HealthGap, regarding a proposed exclusive license to Morphiex Biotherapeutics, an entity for which little is known. The license concerns… Continue Reading
I’m about to deliver this intervention at the WIPO SCCR 36 meeting, as a general statement on limitations and exceptions. We are given 2 minutes. KEI has three points 1. The 1971 Berne Annex, which deals with access for developing… Continue Reading
At the 71st World Health Assembly, KEI will deliver the following intervention regarding the Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018. 11.7 Preparation for… Continue Reading